PMA

P990020: ANEURX STENT GRAFT SYSTEM

FDA PMA · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT · Medtronic Vascular

Key facts

PMA number P990020
Trade name ANEURX STENT GRAFT SYSTEM
Generic name SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant Medtronic Vascular
Owner/operator Medtronic, Inc.
Product code MIH
Approval date Sep 28, 1999
Docket number 99M-4331
Notice date Oct 15, 1999
Establishment registration 2953200
FEI number 3001452571

At a glance

  • 10–99 Supplements
  • Aug 16, 2012 Latest supplement decision
  • Yes Withdrawn
  • Yes Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals